Research Article
Association of RDW, NLR, and PLR with Atrial Fibrillation in Critical Care Patients: A Retrospective Study Based on Propensity Score Matching
Table 1
Characteristics of the patients before propensity score matching (PSM).
| | Parameter | Total | Control | AF | | |
| | Number | | | | | | | Gender (male/female) | 2546/2171 | 1817/1595 | 729/576 | 0.108 | 0.110 | | Age ( (%)) | | | | | | | <45 years | 691 (14.6) | 669 (19.6) | 22 (1.7) | 644.989 | <0.001 | | 45-59 years | 1095 (23.2) | 965 (28.3) | 130 (10.0) | | | | 60-74 years | 1378 (29.2) | 958 (28.1) | 420 (32.2) | | | | ≥75 years | 1553 (32.9) | 820 (24.0) | 733 (56.2) | | | | Smoker | 1514 (32.1) | 1088 (31.9) | 426 (32.6) | 0.248 | 0.619 | | Drinker | 391 (8.3) | 334 (9.8) | 57 (4.4) | 36.493 | <0.001 | | Complications ( (%)) | | | | | | | Hypertension | 1928 (40.9) | 1354 (39.7) | 574 (44.0) | 7.226 | 0.007 | | Diabetes mellitus | 1304 (27.6) | 901 (26.4) | 403 (30.9) | 9.448 | 0.002 | | CAD | 1266 (26.8) | 772 (22.6) | 494 (37.9) | 111.484 | <0.001 | | Heart failure | 1375 (29.1) | 704 (20.6) | 671 (51.4) | 433.154 | <0.001 | | Cardiogenic shock | 109 (2.3) | 56 (1.6) | 53 (4.1) | 24.490 | <0.001 | | Hyperlipidemia | 1477 (31.3) | 984 (28.8) | 493 (37.8) | 35.065 | <0.001 | | Obesity | 119 (2.5) | 79 (2.3) | 40 (3.1) | 2.158 | 0.142 | | Hyperthyroidism | 414 (8.8) | 268 (7.9) | 146 (11.2) | 13.098 | <0.001 | | Pneumonia | 829 (17.6) | 563 (16.5) | 266 (20.4) | 9.823 | 0.002 | | COPD | 129 (2.7) | 82 (2.4) | 47 (3.6) | 5.095 | 0.024 | | Liver disease | 351 (7.4) | 281 (8.2) | 70 (5.4) | 11.302 | <0.001 | | Chronic kidney diseases | 622 (13.2) | 362 (10.6) | 260 (19.9) | 71.530 | <0.001 | | Malignancy | 941 (19.9) | 658 (19.3) | 28 3(21.7) | 3.407 | 0.065 | | Thrombosis | 1065 (22.6) | 708 (20.8) | 357 (27.4) | 23.566 | <0.001 | | AMI | 212 (4.5) | 152 (4.5) | 60 (4.6) | 0.045 | 0.832 | | Stroke | 175 (3.7) | 106 (3.1) | 69 (5.3) | 12.566 | <0.001 | | PE | 154 (3.3) | 117 (3.4) | 37 (2.8) | 1.054 | 0.305 | | DVT | 96 (2.0) | 68 (2.0) | 28 (2.1) | 0.110 | 0.740 | | Other thrombosis | 588 (12.5) | 385 (11.3) | 203 (15.6) | 15.787 | <0.001 | | Blood glucose (mg/dL) | | | | -0.713 | 0.460 | | RBC count (×1012) | | | | 0.981 | 0.327 | | MCV(fL) | | | | -1.228 | 0.219 | | Hemoglobin (g/dL) | | | | 2.109 | 0.035 | | RDW | | | | -5.658 | <0.001 | | WBC count (×109) | | | | -0.726 | 0.468 | | Platelet count (×109) | | | | 1.548 | 0.122 | | Neutrophil count | | | | -2.083 | 0.037 | | Lymphocyte count | | | | 4.057 | <0.001 | | NLR | 6.01 (6.61) | 5.89 (6.50) | 6.35 (6.83) | 9.938 | 0.002 | | PLR | 185.54 (186.34) | 183.56 (187.69) | 190.69 (179.51) | 7.646 | 0.006 | | Sodium (mmol/L) | | | | 0.130 | 0.896 | | Potassium (mmol/L) | | | | -5.320 | <0.001 | | eGFR (mL/min/1.73 m2) | 70.36 (53.00) | 76.13(53.87) | 57.53 (44.39) | 205.801 | <0.001 | | Bun (mg/dL) | 19.0 (18.0) | 17.0 (16.0) | 24.0 (20.0) | 241.124 | <0.001 | | SOFA score | 4 (4) | 3 (4) | 4 (4) | 54.390 | <0.001 | | Vasoactive drugs ( (%)) | 237 (5.0) | 151 (4.4) | 86 (6.6) | 9.268 | 0.002 | | Warfarin ( (%)) | 161 (3.4) | 61 (1.8) | 100 (7.7) | 98.832 | <0.001 | | Aspirin ( (%)) | 700 (14.8) | 446 (13.1) | 254 (19.5) | 30.519 | <0.001 | | Hemodialysis ( (%)) | 240 (5.1) | 152 (4.5) | 88 (6.7) | 10.237 | <0.001 | | Mechanical ventilation ( (%)) | 1454 (30.8) | 1037 (30.4) | 417 (32.0) | 1.079 | 0.299 |
|
|
CAD: coronary artery disease; AMI: acute myocardial infarction; PE: pulmonary embolism; DVT: deep vein thrombosis; COPD: chronic obstructive pulmonary disease; RDW: red cell distribution width; NLR: neutrophil to lymphocyte ratio; MCV: mean corpuscular volume; PLR: platelet to lymphocyte ratio; eGFR: estimated glomerular filtration rate; Bun: blood urea nitrogen; SOFA: Sequential Organ Failure Assessment.
|
